Extension of Time to File SOU

PTO- 1581

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1581

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: VERSEAU (see, http://uspto.report/TM/88003793/mark.png)
SERIAL NUMBER: 88003793

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Verseau Therapeutics, Inc., having an address of
      47 Wiggins Avenue
      Bedford, Massachusetts 01730
      United States
      Email: XXXX
Proposed: Verseau Therapeutics, Inc., having an address of
      47 Wiggins Avenue
      Bedford, Massachusetts 01730
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 01/29/2019.

For International Class 005:
Current identification: Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 042:
Current identification: Pharmaceutical research and development

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the fifth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Joshua S. Jarvis, Esq.
      PRIMARY EMAIL FOR CORRESPONDENCE: ustrademark@foleyhoag.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

Correspondence Information (proposed):
      Joshua S. Jarvis, Esq.
      PRIMARY EMAIL FOR CORRESPONDENCE: ustrademark@foleyhoag.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /John Edwards/      Date Signed: 07/15/2021
Signatory's Name: John Edwards
Signatory's Position: CEO
Signatory's Phone: 6175136299
Signature method: Sent to third party for signature

PAYMENT: 88003793
PAYMENT DATE: 07/15/2021

Serial Number: 88003793
Internet Transmission Date: Thu Jul 15 17:02:26 ET 2021
TEAS Stamp: USPTO/ESU-XX.XX.XX.XXX-20210715170226578
175-88003793-78040aa1ca26a4771a57a48b954
d11c7de16634aeb3938d6bf193814e7dc0107b-C
C-02231312-20210715095828732860